Cost-offset analysis of aprotinin in high-risk coronary artery bypass.

MLA

Meek, P. D., et al. “Cost-Offset Analysis of Aprotinin in High-Risk Coronary Artery Bypass.” Pharmacy Practice Management Quarterly, vol. 19, no. 2, July 1999, pp. 18–25. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10558092&authtype=sso&custid=ns315887.

APA

Meek, P. D., Vlasses, P. H., Sura, M. E., Walsh, R. E., & Vermeulen, L. C. (1999). Cost-offset analysis of aprotinin in high-risk coronary artery bypass. Pharmacy Practice Management Quarterly, 19(2), 18–25.

Chicago

Meek, P D, P H Vlasses, M E Sura, R E Walsh, and L C Vermeulen. 1999. “Cost-Offset Analysis of Aprotinin in High-Risk Coronary Artery Bypass.” Pharmacy Practice Management Quarterly 19 (2): 18–25. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10558092&authtype=sso&custid=ns315887.